JP2025169249A5 - - Google Patents
Info
- Publication number
- JP2025169249A5 JP2025169249A5 JP2025119014A JP2025119014A JP2025169249A5 JP 2025169249 A5 JP2025169249 A5 JP 2025169249A5 JP 2025119014 A JP2025119014 A JP 2025119014A JP 2025119014 A JP2025119014 A JP 2025119014A JP 2025169249 A5 JP2025169249 A5 JP 2025169249A5
- Authority
- JP
- Japan
- Prior art keywords
- rabies virus
- acid sequence
- nucleic acid
- host cell
- vee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762581955P | 2017-11-06 | 2017-11-06 | |
| US62/581,955 | 2017-11-06 | ||
| PCT/EP2018/080086 WO2019086645A1 (en) | 2017-11-06 | 2018-11-05 | Rabies virus vaccine |
| JP2020524280A JP7472019B2 (ja) | 2017-11-06 | 2018-11-05 | 狂犬病ウイルスワクチン |
| JP2023165953A JP7714009B2 (ja) | 2017-11-06 | 2023-09-27 | 狂犬病ウイルスワクチン |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023165953A Division JP7714009B2 (ja) | 2017-11-06 | 2023-09-27 | 狂犬病ウイルスワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025169249A JP2025169249A (ja) | 2025-11-12 |
| JP2025169249A5 true JP2025169249A5 (enExample) | 2025-12-02 |
Family
ID=64316485
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524280A Active JP7472019B2 (ja) | 2017-11-06 | 2018-11-05 | 狂犬病ウイルスワクチン |
| JP2023165953A Active JP7714009B2 (ja) | 2017-11-06 | 2023-09-27 | 狂犬病ウイルスワクチン |
| JP2025119014A Pending JP2025169249A (ja) | 2017-11-06 | 2025-07-15 | 狂犬病ウイルスワクチン |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524280A Active JP7472019B2 (ja) | 2017-11-06 | 2018-11-05 | 狂犬病ウイルスワクチン |
| JP2023165953A Active JP7714009B2 (ja) | 2017-11-06 | 2023-09-27 | 狂犬病ウイルスワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11992526B2 (enExample) |
| EP (1) | EP3706791A1 (enExample) |
| JP (3) | JP7472019B2 (enExample) |
| CN (2) | CN111315409A (enExample) |
| AU (2) | AU2018360288B2 (enExample) |
| BR (1) | BR112020008240A2 (enExample) |
| CA (1) | CA3080425A1 (enExample) |
| WO (1) | WO2019086645A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11167027B2 (en) | 2017-11-06 | 2021-11-09 | Intervet Inc. | Multivalent feline vaccine |
| WO2021228731A1 (en) | 2020-05-11 | 2021-11-18 | Intervet International B.V. | Feline severe acute respiratory syndrome coronavirus 2 vaccine |
| JP2023549787A (ja) | 2020-11-12 | 2023-11-29 | インターベット インターナショナル ベー． フェー． | キメラコロナウイルススパイクタンパク質をコードする組換えベクターおよびその使用 |
| US11730804B1 (en) * | 2022-04-13 | 2023-08-22 | Replicate Bioscience, Inc. | Compositions and methods for the prevention and treatment of rabies virus infection |
| CN119552227B (zh) * | 2023-12-15 | 2025-09-12 | 烟台派诺生物技术有限公司 | 狂犬病病毒g蛋白突变体及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208161B1 (en) * | 1997-05-23 | 2007-04-24 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| US20050266550A1 (en) | 2004-05-18 | 2005-12-01 | Alphavax, Inc. | TC-83-derived alphavirus vectors, particles and methods |
| CN101355960A (zh) * | 2005-10-18 | 2009-01-28 | 诺华疫苗和诊断公司 | 使用α病毒复制子颗粒进行粘膜和全身免疫 |
| TW200907058A (en) * | 2007-05-30 | 2009-02-16 | Wyeth Corp | Raccoon poxvirus expressing rabies glycoproteins |
| US7850977B2 (en) | 2007-06-21 | 2010-12-14 | Alphavax, Inc. | Promoterless cassettes for expression of alphavirus structural proteins |
| PT2635257T (pt) * | 2010-11-05 | 2017-08-16 | Novavax Inc | Partículas semelhantes a vírus de glicoproteína de raiva (vlps) |
| CN104105504A (zh) * | 2011-10-11 | 2014-10-15 | 诺华股份有限公司 | 重组多顺反子核酸分子 |
| WO2013138776A1 (en) * | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| CN110195072A (zh) * | 2013-08-21 | 2019-09-03 | 库瑞瓦格股份公司 | 狂犬病疫苗 |
-
2018
- 2018-11-05 EP EP18803571.1A patent/EP3706791A1/en active Pending
- 2018-11-05 BR BR112020008240-6A patent/BR112020008240A2/pt unknown
- 2018-11-05 JP JP2020524280A patent/JP7472019B2/ja active Active
- 2018-11-05 CA CA3080425A patent/CA3080425A1/en active Pending
- 2018-11-05 AU AU2018360288A patent/AU2018360288B2/en active Active
- 2018-11-05 CN CN201880071826.3A patent/CN111315409A/zh active Pending
- 2018-11-05 CN CN202410181783.1A patent/CN118490817A/zh active Pending
- 2018-11-05 WO PCT/EP2018/080086 patent/WO2019086645A1/en not_active Ceased
- 2018-11-05 US US16/759,868 patent/US11992526B2/en active Active
-
2023
- 2023-09-27 JP JP2023165953A patent/JP7714009B2/ja active Active
-
2025
- 2025-07-15 JP JP2025119014A patent/JP2025169249A/ja active Pending
- 2025-08-21 AU AU2025220796A patent/AU2025220796A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025169249A5 (enExample) | ||
| CA2410948C (en) | Method for the purification of alphavirus replicon particles | |
| Sanchez et al. | Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus | |
| Kinney et al. | Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins | |
| Rager et al. | Polyploid measles virus with hexameric genome length | |
| JP2025169275A5 (enExample) | ||
| JP2023134488A5 (enExample) | ||
| CA2567254A1 (en) | Tc-83-derived alphavirus vectors, particles and methods | |
| JP2015119730A5 (enExample) | ||
| JP2004501647A5 (enExample) | ||
| EP3805385B1 (en) | Lentiviral vector and method for delivering exogenous rna by the lentiviral vector | |
| McGettigan et al. | Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome | |
| JP2004513616A5 (enExample) | ||
| JP2019519252A5 (enExample) | ||
| JP2010530245A5 (enExample) | ||
| JP2015522581A5 (enExample) | ||
| WO2002099035A2 (en) | Chimeric alphavirus replicon particles | |
| AU2002303330A1 (en) | Chimeric alphavirus replicon particles | |
| JP2011182797A5 (enExample) | ||
| JP2024180560A5 (enExample) | ||
| WO2023035372A1 (zh) | 一种有限自我复制mRNA分子系统、制备方法及应用 | |
| JP2025170230A5 (enExample) | ||
| JP2023184757A5 (enExample) | ||
| CN118206622A (zh) | RSV融合前F蛋白的突变体、核酸及mRNA疫苗 | |
| CN118903403A (zh) | 虹鳟特异性CpG佐剂及其应用、虹鳟传染性造血器官坏死病核酸疫苗 |